Abstract
We report here a case of severe steroid-refractory gastrointestinal graft-versus-host disease treated with intra-arterial administration of corticosteroids. A 53-year-old female with non-Hodgkin's lymphoma received peripheral blood hematopoietic stem cell transplant from her HLA-matched sibling. She developed grade II skin and grade IV gastrointestinal graft-versus-host disease with no hepatic involvement. Therapy with oral prednisone easily controlled her skin rash but she had profuse diarrhea that did not respond to high dose intravenous corticosteroids and denileukin diftitox. Infusion of methyl-prednisolone into superior and inferior mesenteric arteries produced dramatic improvement of diarrhea, with complete resolution of gastrointestinal graft-versus-host disease.
MeSH terms
-
Administration, Oral
-
Antineoplastic Agents / administration & dosage
-
Diarrhea / drug therapy
-
Diarrhea / etiology
-
Diarrhea / pathology
-
Diphtheria Toxin / administration & dosage
-
Drug Resistance / drug effects
-
Female
-
Gastrointestinal Diseases / drug therapy*
-
Gastrointestinal Diseases / etiology
-
Gastrointestinal Diseases / pathology
-
Glucocorticoids / administration & dosage*
-
Graft vs Host Disease / drug therapy*
-
Graft vs Host Disease / etiology
-
Graft vs Host Disease / pathology
-
Humans
-
Infusions, Intra-Arterial / methods
-
Injections, Intravenous / methods
-
Interleukin-2 / administration & dosage
-
Lymphoma, Follicular / complications
-
Lymphoma, Follicular / pathology
-
Lymphoma, Follicular / therapy*
-
Methylprednisolone / administration & dosage*
-
Middle Aged
-
Peripheral Blood Stem Cell Transplantation* / adverse effects
-
Prednisone / administration & dosage
-
Recombinant Fusion Proteins / administration & dosage
-
Skin Diseases / drug therapy
-
Skin Diseases / etiology
-
Skin Diseases / pathology
Substances
-
Antineoplastic Agents
-
Diphtheria Toxin
-
Glucocorticoids
-
Interleukin-2
-
Recombinant Fusion Proteins
-
denileukin diftitox
-
Prednisone
-
Methylprednisolone